About the Journal | Hepatoma Research

Hepatoma Research is an international peer-reviewed, open access, online journal.

Aims and Scope

Hepatoma Research focuses on research related to liver cancer, biliary tract cancers, and liver diseases. It covers topics such as their occurrence, development, diagnosis, prevention, and treatment. The journal publishes high-quality basic, translational, clinical, and population-based studies across the continuum of liver oncology and related disciplines.

The scope of the journal includes the following areas:

• Liver cancer (primary focus)
Liver cancer, with a focus on hepatocellular carcinoma, including etiologically and biologically defined disease subtypes associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, metabolic dysfunction, inflammation, immune dysregulation, and viral evolution.
Development and validation of diagnostic, prognostic, and predictive biomarkers for liver cancer, including molecular, imaging, and multi-parameter biomarkers relevant to early detection, risk stratification, and assessment of treatment response.
Therapeutic strategies and clinical management of liver cancer, including basic and clinical research on animal models, liver transplantation, surgical and interventional therapies, molecular targeted therapy, immunotherapy, combination treatment strategies, treatment-related drugs and complications, and the clinical translation of emerging laboratory discoveries.

• Biliary tract cancers
Molecular and cellular mechanisms underlying biliary tract cancers, particularly intrahepatic cholangiocarcinoma, with relevance to liver oncology.
Diagnostic, prognostic, and predictive biomarkers for biliary tract cancers.
Clinical management and therapeutic approaches for biliary tract cancers, including surgical, interventional, systemic, and translational treatment strategies.

• Chronic liver diseases associated with liver cancer risk
Chronic liver diseases that are associated with an increased risk of liver cancer include chronic viral hepatitis, metabolic dysfunction–associated steatotic liver disease, alcohol-related liver disease, liver fibrosis, cirrhosis, and immune-mediated liver diseases.
Risk stratification, surveillance strategies, and preventive interventions for liver cancer in patients with high-risk liver diseases.
Translational studies linking chronic liver disease biology to hepatocarcinogenesis and early malignant transformation.

• Epidemiology and public health
Descriptive epidemiological studies of liver cancer and biliary tract cancers, including an analysis of time trends in incidence, mortality, survival, and disease burden (e.g. DALY).
Clinical follow-up or survival studies aimed at evaluating or investigating the prognostic predictive model and the prognostic factors of liver cancer.
Population-based investigations of chronic liver diseases as risk factors for liver cancer.
Predictive risk modeling, public health strategies, and active prevention of liver cancer and biliary tract cancers. Large-scale cohort studies and randomized controlled clinical trials are particularly welcome.

Ownership

The journal is owned by OAE Publishing Inc.

Publishing Model

Gold open access. All articles published by Hepatoma Research are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access.

Copyright and License to Publish

Articles in Hepatoma Research had been published under Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) by October 2017, whereas the Creative Commons Attribution 4.0 International (CC BY 4.0) was further adopted afterwards. The CC BY 4.0 allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.

Copyright is retained by authors. Authors are required to sign a License to Publish (which can be downloaded from the journal's Author Instructions), granting Hepatoma Research, which identifies itself as the original publisher, exclusive rights to publish their articles, and granting any third party the right to use the articles freely as long as the integrity is maintained and the original authors, citation details and publisher are identified.

Editorial Board

For more information about the editorial team, please refer to Editorial Board.

Editorial Policies

All manuscripts submitted to Hepatoma Research should adhere to Hepatoma Research's Editorial Policies.

Peer Review

The journal adheres to a rigorous peer review process and undergoes single-blind peer review. For more details, please refer to Editorial Process and Peer Review Guidelines.

Publication Ethics Statement

Hepatoma Research is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines.

The Editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to guarantee to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The Editors of Hepatoma Research take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.

Journal Information and Statistics

Launch date: April 15, 2015
Publication model: Open access
Online ISSN: 2454-2520
Print ISSN: 2394-5079
Digital archive: Portico
Frequency: Continuously published
DOI: 10.20517/2394-5079

Indexing & Archiving

All articles published in Hepatoma Research are included in:

Contact

Please visit the Contact Us for details about different queries.